Policy changes Backwork has recorded, newest first. The most recent change on record is from October 14, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
83,427 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Leqvio (inclisiran) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Leadless Cardiac Pacemakers | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laser Treatment of Onychomycosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laser Treatment of Congenital Port Wine Stain Hemangiomas | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laser Interstitial Thermal Therapy for Neurological Conditions | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laparoscopic, Percutaneous, and Transcervical Techniques for Uterine Fibroid Myolysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laboratory Tests Post Transplant and for Heart Failure | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Laboratory and Genetic Testing for Use of 5-Fluorouracil in Patients With Cancer | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Kuvan (sapropterin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Krystexxa (pegloticase) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Koselugo (selumetinib) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Korsuva (difelikefalin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Knee Arthroplasty - West Central and North East Region | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Kimyrsa (oritavancin) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | KIF6 Genotyping for Predicting Cardiovascular Risk and/or Effectiveness of Statin Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Kidney Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Keratoprosthesis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Kebilidi (eladocagene exuparvovec-tneq) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Jynarque (tolvaptan) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | JAK2, MPL, and CALR Testing for Myeloproliferative Neoplasms | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Itvisma (onasemnogene abeparvovec-brve) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isturisa (osilodrostat) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isotretinoin Products | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Isolated Small Bowel Transplant | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Islet Transplantation for Chronic Pancreatitis and Donislecel-jujn for Type 1 Diabetes | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Irreversible Electroporation of Tumors Located in the Liver, Pancreas, Kidney, Lung, or Prostate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Invasive Prenatal (Fetal) Diagnostic Testing | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravitreal Angiogenesis Inhibitors | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Nutrient Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Iron Replacement Therapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Antibiotic Therapy and Associated Diagnostic Testing for Lyme Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intravenous Anesthetics for the Treatment of Chronic Pain and Psychiatric Disorders | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraoperative Radiotherapy | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraoperative Neurophysiologic Monitoring | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intraocular Radiotherapy for Age-Related Macular Degeneration | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intradialytic Parenteral Nutrition | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracoronary Drug Delivery Balloon Procedures | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracellular Micronutrient Analysis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intracavitary Balloon Catheter Brain Brachytherapy for Malignant Gliomas or Metastasis to the Brain | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intra-articular Hyaluronan Injections for Osteoarthritis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interventions for Progressive Scoliosis | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interstitial Lung Disease | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interspinous Fixation (Fusion) Devices | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interspinous and Interlaminar Stabilization/Distraction Devices (Spacers) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interleukin-5 Antagonist Monoclonal Antibodies | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interleukin-1 Inhibitors (Arcalyst, Ilaris, Kineret) | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interim PET Scanning in Oncology to Detect Early Response During Treatment | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Interferential Current Stimulation | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Prostate | New policy |
| Aug 2, 2026 | Blue Cross & Blue Shield of Mississippi | Intensity-Modulated Radiotherapy (IMRT): Central Nervous System Tumors | New policy |